JONBUR Research · Initiation

You're reading an earlier report from Oct 20, 2026. See the latest report

KC · 029460 · Medical & precision devices

KC: Low Multiples and Steady Revenue as Sale Headlines Emerge

Why this report

Start of coverage: written when a reader opened this company and there was no report yet.

KC closed at ₩37,600 on 2026-10-19, up 35.7% over three months but down 9.0% over one month, with a market cap of ₩414.4B. News on 2026-10-16 reports a consortium selected as preferred bidder for a ₩300B deal, while the data shows trailing multiples well below the listed peers.

Written Oct 20, 2026 · Data as of Oct 19, 2026 · 0 views

This is not financial advice. The report does not recommend buying or selling anything.

Thesis

The data supports a picture of a company trading at low multiples (P/E 7.6, P/B 0.4, EV/EBITDA 5.0) with modest profitability (ROE 6.3%) and a very light balance sheet. Foreign ownership rose from 11.7% to 14.5% over 60 days, and filings show several shareholding reports and changes in the largest shareholder's holdings. Two headlines from 2026-10-16 mention a consortium selected as preferred bidder for an acquisition valued at ₩300B. The data does not give the terms, the stake involved, the timing or whether the deal will complete, so the news cannot be assessed further. The model estimate sits below the current price, while the low multiples point the other way, so the evidence is mixed.

Business overview

KC is listed on KOSPI and classified in medical and precision devices. It was founded in 1987 and listed in 1997, with 11,020,535 listed shares and two co-CEOs. Trailing revenue to H1 2026 was ₩814.0B. Annual revenue was ₩553.8B in 2021, ₩858.0B in 2022 (up 54.9%), ₩727.0B in 2023 (down 15.3%), ₩738.5B in 2024 (up 1.6%) and ₩797.3B in 2025 (up 8.0%). One headline describes the company as a marine parts maker, which the sector data does not clarify.

Every earlier JONBUR Research report and update note on KC, with Pro.

Unlock with Pro

Model estimate of fair value

Bear
₩5,998
-84%
Base
₩22,540
-38%
Bull
₩51,589
+41%

Model estimate based on the assumptions shown. Not a price target and not a buy or sell signal.

Base case of the 5-year discounted cash flow model on the stock's Valuation tab (statements TTM to H1 2026; discount rate 7.9%). Bear and Bull move the main assumptions by fixed steps. See and change the assumptions

Filings and data used

Report history

  1. Oct 21, 2026Update noteModel fair value changeKC: Model Fair Value Estimate Rises to ₩58,003 Per Share From ₩22,540
  2. Oct 20, 2026InitiationStart of coverage (reader request)KC: Low Multiples and Steady Revenue as Sale Headlines Emerge

Built only from jonbur's own data: prices and investor flows, filed financial statements and filings, and news headlines. Disclosed (filed) data is labelled as such. Written by AI and may contain mistakes.

This is not financial advice. The report does not recommend buying or selling anything.

Source: KRX statistical information